Herpes Infections In Children And Nonpregnant Adults
<!– @page { size: 21cm 29.7cm; margin: 2cm } P { margin-bottom: 0.21cm } –>
Virtually all herpetic orolabial disease is caused by HSV-1. The geographic distribution of HSV-1 is worldwide, with infection occurring in both developed and underdeveloped countries. Animal vectors for human HSV infections have not been described, and humans remain the sole reservoir for transmission to other humans.
Virus is transmitted from infected to susceptible individuals during close personal contact. There is no seasonal variation in the incidence of infection. Because infection is rarely fatal and HSV establishes latency, over one-third of the world’s population has recurrent HSV infections and hence, the capability of transmitting HSV during episodes of productive infection.
As such, recurrent herpes labialis is the largest reservoir of HSV infections in the community. Using type-specific serologic assays, the seroprevalence of HSV-1 infections in the United States has been redefined utilizing sera obtained from the randomized National Health and Nutrition Examination Survey.
By the age of 5 years, over 35% of black children and 18% of white children are infected by HSV-1. Through adolescence, blacks have approximately a twofold higher prevalence of antibodies to HSV-1 than do whites, and females have a slightly higher antibody prevalence than do males. By the age of 40 years, both blacks and whites have a similar prevalence of antibodies, with 70 to 80% being HSV-1 seropositive.
A similarly high prevalence of antibodies to HSV-1 exists among persons worldwide, although a high degree of country-to-country variability is seen. Genital herpes infections are caused by HSV-2 or HSV-1. Epidemiologic studies of HSV-2 seroprevalence accurately reflect HSV-2-associated genital disease burden.
Similar studies of HSV-1 seroprevalence are not of equal utility in determining the magnitude of HSV-1-associated genital disease burden, because a majority of adults have acquired HSV-1 orolabial infections by the time they reach adulthood, as described above. Seroepidemiologic studies thus cannot distinguish a person with HSV-1 antibody due to prior orolabial infection from someone with prior HSV-1 genital disease.
When a person with no prior HSV-1 or HSV-2 antibody acquires either virus in the genital tract, a first-episode primary infection results. If a person with preexisting HSV-1 antibody acquires HSV-2 genital infection, a first-episode nonprimary infection ensues. Viral reactivation from latency and subsequent antegrade translocation of virus back to the skin and mucosal surfaces produces a recurrent infection.
HSVCurative is a potent all natural antiviral cure for herpes, highly effective against HSV1 and HSV2. It has a wide spectrum of antiviral activity against these viruses, even for genital herpes. The cure in this treatment has the ability to inactivate and destroy HSV, which has been established in published clinical trials. It is to be applied directly to an outbreak.
HSVCurative is used specifically to treat HSV1 and HSV2 infections and acts as a curative agent against both these strains of herpes. It exhibits a pronounced anti-herpetic activity against HSV1 and HSV2 and, unlike other cures for herpes, actually kills these viruses upon exposure regardless of location on the body.
HSVCurative is formulated at maximum strength and has produced spectacular results above other potential herpes cures in eliminating herpes outbreaks in almost all known cases of use on herpes. It is possibly the most powerful and effective topical herpes treatment on the market, providing total clearance of outbreaks time after time.
HSVCurative contains certified organic medicinal plant extracts and antiviral essential oils which cause cellular death to HSV1 and HSV2 in scientific studies. HSVCurative has a rather remarkable array of pharmacological and biochemical properties which inactivate and destroy the herpes virus for unprecedented results compared to other cures for herpes.
HSVCurative can be used to treat HSV1 or HSV2 infections occurring anywhere on the body. Users of HSVCurative usually experience quick elimination of outbreaks, without scarring or tissue damage. In almost all cases, application of HSVCurative quickly provides a cure for herpes outbreaks. To learn more, please go to http://www.bcured.net.
